No postpetition borrowing outside DIP facilities
Company: Core Scientific
The claim, verbatim
The company stated that all postpetition borrowings since the start of the case, other than trade credit, were made under the Initial DIP Facility or the Replacement DIP Facility, and there was no such borrowing during the August 2023 period.
Source (primary)
core-scientific 8-K exhibit (d331696dex991.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-19)Live source ↗
Quote: “All postpetition borrowings since the inception of the case, other than trade credit, are borrowings made under the Initial DIP Facility or the Replacement DIP Facility.”
How we checked this
Checked on November 20, 2026. The cited source supports every part of this claim.
The report's notes attribute all non-trade-credit postpetition borrowing to the two DIP facilities, and the questionnaire for the August 2023 period answers 'No' to any such borrowing.
Confirmed in the source:
- Core Scientific stated that all postpetition borrowings since the inception of the case, other than trade credit, were made under the Initial DIP Facility or the Replacement DIP Facility
- Core Scientific answered 'No' to whether there was any postpetition borrowing other than trade credit during the August 1–31, 2023 reporting period
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523247529/d331696dex991.htm) in full (33,373 characters, retrieved November 19, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d331696dex991.htm)
Quote: “All postpetition borrowings since the inception of the case, other than trade credit, are borrowings made under the Initial DIP Facility or the Replacement DIP Facility.”